Vtrade Proposes to Buy Align Technology Inc.

1. PROPOSED US EQUITY TRADE
Align Technology Inc. (NASDAQ: ALGN)

2.  Company Profile
 Vtrade Recommendation
 Stock Chart
 Reasons to Buy / Sell
 Company Financials / Earnings

3. Align Technology Inc.
Founded in –1997 | Current Market Cap – 26.30 Billion USD
Align Technology, Inc. designs, manufactures, and markets a system of
clear aligner therapy, intraoral scanners, and computer-aided design and
computer-aided manufacturing (CAD/CAM) digital services. The
company’s Clear Aligner segment offers Invisalign Full, a treatment used
for a range of malocclusion; Invisalign Teen treatment that addresses
orthodontic needs of teenage patients, such as compliance indicators,
compensation for tooth eruption, and six free single arch replacement
aligners; and Invisalign Assist treatment for anterior alignment and
aesthetically-oriented cases. It also provides Invisalign Express (10 and
5) and Invisalign Lite/i7 treatments for orthodontic cases, non-
comprehensive treatment relapse cases, or straightening prior to
restorative or cosmetic treatments. The company is headquartered in
San Jose, California.

4. We recommend to BUY Align Technology at USD 312,
for a target of USD 351 in two months.

5.  Align Technology has been outperforming its industry over the past year. The stock
has gained 100.9% in comparison to the industry's 14.7% gain. The company
started off 2018 on a solid note. Align Technology ended the second quarter on a
solid note. We are optimistic about continued strength in Invisalign volumes. The
company’s upbeat Invisalign Technology prospects and growth in North America
and outside, particularly in the Asia-Pacific and EMEA regions. The strong uptake
of iTero scanners across all geographies is impressive as well. Further, Align
Technology’s receipt of CFDA approval to manufacture the iTero Element intraoral
scanner in China buoys optimism. We are also upbeat about the company
expanding the iTero Element portfolio with the launch of iTero Element 2 and iTero
Element Flex scanners.
 In EMEA, second-quarter volumes were up 38% on solid adoption of Invisalign
technology in markets like Eastern Europe and Central Europe. In the APAC region,
the company witnessed second-quarter volume growth of 58.7%, led by China,
Japan, Australia and New Zealand.

6.  In sync with its last-year performance, Align Technology continued with its streak
of delivering a strong InvisAlign Technology volume growth across the company’s
entire customer base. In North America, Invisalign Technology case volumes grew
22.2% in the second quarter. Volumes were also up 45.4% year over year
internationally. Moreover, management observed solid demand for Align
Technology’s new iTero Element scanner, thereby resulting in scanner revenue
growth of 60.9% year over year. Geographically, the company witnessed strength in
North America as well as overseas. In North America, the company continued to
witness an expanding GP Dentist customer base along with sustained strength in
Invisalign utilization by orthodontists. Internationally, we are encouraged by solid
performance in the Europe, Middle East and Africa (EMEA) and Asia Pacific
(APAC) markets.
 Align Technology has been focusing on expanding work flow options of its leading
iTero scanners. The company has been gaining from shipments of the iTero
Element intraoral scanner to China. Moreover, it received the Certificate of Medical
Device Registration and Certificate of Production from the China Food and Drug
Administration (CFDA) to manufacture the iTero Element intraoral scanner in
China.

7.  Align Technology witnessed sales growth across all channels in the second quarter.
Revenues at the Clear Aligner segment (88.4% of total revenues) soared 35% year
over year driven by growth in North America and international regions from
expanded customer base and increased utilization along with solid worldwide teen
case growth. In the same time, InvisAlign Technology case shipments were up
30.5% year over year on growth across all regions as well as expansion of customer
base. During the quarter, Align Technology Invisalign cases were shipped to 50,085
doctors worldwide, of which 28,280 were to North America and 21,805 to
international regions.
 The Sales from Scanner and Service (which account for rest of the revenues) rose
60.9% year over year. The company witnessed strong uptake of iTero scanners
across all geographies. Moreover, the company continues to see increased adoption
of iTero scanners for Invisalign case submissions instead of PVS impressions,
thereby driving Invisalign utilization. Moreover, Align Technology has been gaining
from shipments of the iTero Element intraoral scanner to China.
 For more details on Reasons to BUY visit our blog -
https://vtradecapitalservices.blogspot.com/

8.  Align Technology's second-quarter 2018 adjusted earnings per share (EPS) came in at
$1.30, up 52.9% year over year. Earnings also came above the company’s guided range
of $1.02-$1.06. The figure comfortably beat the Consensus Estimate of $1.09 as well.
 Revenues grew 37.5% year over year to $490.3 million in the quarter, surpassing the
Consensus Estimate of $469.2 million. Revenues were well ahead of the company’s
guided range of $460-$470 million.

9. CAYMAN ISLANDS LONDON REACH US
PO BOX, 847, G.T., 88 Wood Street, Mr. Harish R.
KY1-1103, 10th Floor, Head – Sales & Marketing
Grand Cayman, London EC2V 7RS Mob: +971 55 602 7786
Cayman Islands. United Kingdom. Email: harish@vtrades.net
THANK YOU!!!